Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone in infantile spasms (dose-ranging, double-blind, placebo-controlled)
2006-004285-13Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Mar 2007
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in West syndrome comparing Ganaxolone ascending dose with Placebo (2 arms). Primary endpoints: Spasm frequency on 24-hour video EEG and Safety and tolerability of ascending doses of ganaxolone. Started Mar 2007; status: completed.
02
Drugs
ganaxolone
03
Conditions
West syndrome
Beyond the preview
Go deeper on 2006-004285-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004285-13.